Susquehanna International Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-95,000
| Closed | -$1.42M | – | 14254 |
|
|
2022
Q4 | $1.42M | Sell |
95,000
-131,900
| -58% | -$1.83M | ﹤0.01% | 5406 |
|
|
2022
Q3 | $1.87M | Buy |
226,900
+21,500
| +10% | +$165K | ﹤0.01% | 5051 |
|
|
2022
Q2 | $1.35M | Buy |
205,400
+7,300
| +4% | +$35.4K | ﹤0.01% | 5809 |
|
|
2022
Q1 | $1.11M | Buy |
198,100
+21,600
| +12% | +$89K | ﹤0.01% | 6860 |
|
|
2021
Q4 | $828K | Buy |
176,500
+28,300
| +19% | +$176K | ﹤0.01% | 7794 |
|
|
2021
Q3 | $916K | Sell |
148,200
-18,800
| -11% | -$112K | ﹤0.01% | 7802 |
|
|
2021
Q2 | $1.1M | Sell |
167,000
-151,900
| -48% | -$1.05M | ﹤0.01% | 7501 |
|
|
2021
Q1 | $2.33M | Buy |
318,900
+112,100
| +54% | +$967K | ﹤0.01% | 5550 |
|
|
2020
Q4 | $1.19M | Sell |
206,800
-36,500
| -15% | -$209K | ﹤0.01% | 6307 |
|
|
2020
Q3 | $1.45M | Sell |
243,300
-67,300
| -22% | -$333K | ﹤0.01% | 5253 |
|
|
2020
Q2 | $1.6M | Buy |
310,600
+165,600
| +114% | +$1.05M | ﹤0.01% | 4903 |
|
|
2020
Q1 | $525K | Buy |
145,000
+89,580
| +162% | +$445K | ﹤0.01% | 6840 |
|
|
2019
Q4 | $346K | Buy |
55,420
+4,980
| +10% | +$36.7K | ﹤0.01% | 7738 |
|
|
2019
Q3 | $426K | Sell |
50,440
-26,240
| -34% | -$195K | ﹤0.01% | 7636 |
|
|
2019
Q2 | $516K | Sell |
76,680
-44,130
| -37% | -$378K | ﹤0.01% | 7201 |
|
|
2019
Q1 | $991K | Sell |
120,810
-56,150
| -32% | -$580K | ﹤0.01% | 5062 |
|
|
2018
Q4 | $2.83M | Sell |
176,960
-17,900
| -9% | -$394K | ﹤0.01% | 3029 |
|
|
2018
Q3 | $6.45M | Buy |
194,860
+87,950
| +82% | +$2.26M | ﹤0.01% | 2374 |
|
|
2018
Q2 | $2.42M | Buy |
106,910
+45,170
| +73% | +$1.07M | ﹤0.01% | 3707 |
|
|
2018
Q1 | $1.79M | Sell |
61,740
-11,870
| -16% | -$347K | ﹤0.01% | 4128 |
|
|
2017
Q4 | $2.05M | Buy |
73,610
+12,860
| +21% | +$399K | ﹤0.01% | 3864 |
|
|
2017
Q3 | $2.22M | Buy |
60,750
+33,510
| +123% | +$1.04M | ﹤0.01% | 3717 |
|
|
2017
Q2 | $605K | Buy |
+27,240
| New | +$214K | ﹤0.01% | 6277 |
|
|
2015
Q4 | – | Sell |
-1,370
| Closed | -$17K | – | 10248 |
|
|
2015
Q3 | $17K | Sell |
1,370
-3,140
| -70% | -$45.4K | ﹤0.01% | 9514 |
|
|
2015
Q2 | $78K | Buy |
+4,510
| New | +$81.2K | ﹤0.01% | 9761 |
|
Susquehanna International Group's AVEO Position: Q1 2023 in Review
Susquehanna International Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 439,159 shares — an estimated $6.57M sold.
Susquehanna International Group first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $6.57M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Susquehanna International Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group sold 439,159 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6.57M.
- Susquehanna International Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
- Susquehanna International Group's AVEO Pharmaceuticals, Inc. position peaked at $6.57M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.